September 25, 2017
College Park Marriott / Hyattsville, MD


The survey is now closed.  Thanks to everyone who took the time to fill it out and helped advance the Lupus Patient-Focused Drug Development Initiative.

The survey was designed to give people with lupus a channce to add their voices and tell the organizers and the FDA about their experience being diagnosed with lupus, living with the disease and pursuing treatment options. Over 2,000 people from the U.S. and across the globe completed the survey. The survey data helped us plan the Lupus PFDD Meeting and will help us develop a report on the lupus patient experience that will be shared with the FDA. Thanks to everyone who took the time to complete the survey!